Companies (6)

CHEYENNE RESOURCES CORPORATION
Logo Cheyenne Resources Corporation

Cheyenne Resources Corp. is focused on developing shallow natural gas and oil wells in Northeastern Oklahoma. The Company is an independent energy development firm primarily engaged in the exploration, development, and production of oil and natural gas. T ...

Capitalization 55 USD
Change-.--%
1-year price change-.--%
ONLINE BRANDS NORDIC AB
Logo Online Brands Nordic AB

Online Brands Nordic AB, formerly Onskefoto AB, is a Sweden-based company engaged in the jewelry sector. The Company operates online shops with jewelry made primarily of gold and silver, namely hedbergsguld.se and jewel.se, as well as operates a shop in D ...

Capitalization 34 M USD
Change-11.01%
1-year price change+28.64%
PROTARA THERAPEUTICS, INC.
Logo Protara Therapeutics, Inc.

Protara Therapeutics, Inc. is a clinical-stage biotechnology company, which is engaged in advancing transformative therapies for people with cancer and rare diseases. The Company’s portfolio includes its lead candidate, TARA-002, an investigational cell ...

Capitalization 55 M USD
Change-1.12%
1-year price change+41.33%
CG ONCOLOGY, INC.
Logo CG Oncology, Inc.

CG Oncology, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The Company’s product candidate, cretostimogene i ...

Capitalization 2 326 M USD
Change+1.59%
1-year price change0.00%
ENGENE HOLDINGS INC.
Logo enGene Holdings Inc.

enGene Holdings Inc. is a holding company. The Company, through its subsidiary, enGene Inc., is engaged in developing non-viral gene therapies based on localized delivery of nucleic acid payloads to mucosal tissues. The Company’s proprietary dually deri ...

Capitalization 375 M USD
Change+3.27%
1-year price change-13.87%
VACCINOGEN INC
Logo Vaccinogen Inc

Vaccinogen, Inc. is a biotechnology company. The Company is the developer of OncoVAX. OncoVAX is an active specific immunotherapy (ASI) that uses the patient's own cancer cells to create a vaccine that in turn is used to block the return of cancer followi ...

Capitalization - USD
Change-.--%
1-year price change-.--%

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW